Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

F Mahfoud, M Schlaich, I Kindermann, C Ukena… - Circulation, 2011 - Am Heart Assoc
Background—Hypertension is associated with impaired glucose metabolism and insulin
resistance. Chronic activation of the sympathetic nervous system may contribute to either …

Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension

MP Schlaich, D Hering, P Sobotka, H Krum… - Frontiers in …, 2012 - frontiersin.org
Increased central sympathetic drive is a hallmark of several important clinical conditions
including essential hypertension, heart failure, chronic kidney disease, and insulin …

Renal sympathetic denervation as second‐line therapy in mild resistant hypertension: a pilot study

B Kaltenbach, J Franke, SC Bertog… - Catheterization and …, 2013 - Wiley Online Library
Background Catheter‐based renal sympathetic denervation (CRD) is associated with
significant blood pressure (BP) reductions in patients with severe therapy‐resistant …

Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?

M Böhm, D Linz, C Ukena, M Esler… - Circulation research, 2014 - Am Heart Assoc
Hypertension imposes a major burden of morbidity and mortality and is associated with
sympathetic nervous system overactivity. Renal sympathetic denervation has been shown to …

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

Symplicity HTN-2 Investigators - The Lancet, 2010 - Elsevier
BACKGROUND: Activation of renal sympathetic nerves is key to pathogenesis of essential
hypertension. We aimed to assess effectiveness and safety of catheter-based renal …

Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial

MD Esler, H Krum, M Schlaich, RE Schmieder… - Circulation, 2012 - Am Heart Assoc
Background—Renal sympathetic nerve activation contributes to the pathogenesis of
hypertension. Symplicity HTN-2, a multicenter, randomized trial, demonstrated that catheter …

Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months

Symplicity HTN-1 Investigators - Hypertension, 2011 - Am Heart Assoc
Renal sympathetic hyperactivity is seminal in the maintenance and progression of
hypertension. Catheter-based renal sympathetic denervation has been shown to …

Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension

S Desch, T Okon, D Heinemann, K Kulle, K Röhnert… - …, 2015 - Am Heart Assoc
Few data are available with regard to the effectiveness of renal sympathetic denervation in
patients with resistant hypertension yet only mildly elevated blood pressure (BP). Patients …

Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea

A Witkowski, A Prejbisz, E Florczak, J Kądziela… - …, 2011 - Am Heart Assoc
Percutaneous renal sympathetic denervation by radiofrequency energy has been reported
to reduce blood pressure (BP) by the reduction of renal sympathetic efferent and afferent …

[PDF][PDF] Renal denervation to treat resistant hypertension: guarded optimism

G Thomas, MH Shishehbor, EL Bravo, JV Nally - Cleve Clin J Med, 2012 - cdn.mdedge.com
Renal sympathetic denervation has shown promise in treating hypertension resistant to drug
therapy. This procedure lowers blood pressure via targeted attenuation of renal sympathetic …